2022 News

Stay up to date on all that’s happening at Santen USA. For our global headquarters news, visit Santen Worldwide.

News

10.06.2022 Santen Announces Health Canada Approval for Cationorm® Plus to Relieve the Symptoms of Dry Eye and Ocular Allergy

09.26.2022 Santen and UBE Received FDA Approval for OMLONTI® (Omidenepag Isopropyl Ophthalmic Solution) 0.002% for the Reduction of Elevated Intraocular Pressure in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

05.08.2022 Santen Reports Consolidated Results for Fiscal 2021

05.02.2022 Santen’s Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% Now Available for the Treatment of Vernal Keratoconjunctivitis in Children and Adults in the United States

02.14.2022 Santen Reports 3rd Quarter Fiscal 2021 Performance

Copyright © 2023 Santen Pharmaceutical Co., Ltd.
All Rights Reserved